Telbivudine 13C, 15N2

[13C, 15N2]-Telbivudine is a molecular compound that is used in the treatment of hepatitis B virus (HBV) infection. It is an isotopically labeled version of Telbivudine, a nucleoside reverse transcriptase inhibitor that works by blocking the replication of HBV in the body. The isotopic labeling of [13C, 15N2]-Telbivudine allows for the tracking and monitoring of the drug's metabolic pathways in the body, which can provide valuable insights into its pharmacokinetic and pharmacodynamic properties. The chemical structure of [13C, 15N2]-Telbivudine consists of a pyrimidine base attached to a ribose sugar unit, with two isotopes of carbon (13C) and nitrogen (15N) incorporated into the structure. The isotopic labeling of the compound does not alter its therapeutic properties, but it does enable researchers to study its behavior in the body more closely. [13C, 15N2]-Telbivudine is typically administered orally in tablet form, with dosages and treatment regimens varying depending on the severity of the HBV infection and other patient-specific factors. Overall, [13C, 15N2]-Telbivudine is a valuable tool for studying the metabolism and pharmacokinetics of Telbivudine, which is an important drug in the treatment of HBV infection. Its isotopic labeling provides researchers with a powerful tool for understanding how the drug works in the body, which could ultimately lead to more effective treatments for this challenging disease.